Twin Tree Management, LP Biomarin Pharmaceutical Inc Call Options Transaction History

Twin Tree Management, LP

  • $50 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 11, 2022
BUY
$74.28 - $92.69 $81,708 - $101,959
1,100 Added 25.58%
5,400 $416,000
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $336,285 - $408,105
-4,500 Reduced 51.14%
4,300 $325,000
Q3 2020

Nov 13, 2020
BUY
$71.87 - $131.03 $632,456 - $1.15 Million
8,800 New
8,800 $670,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email